Gradient Corporation, Cambridge, MA 02138, USA.
Regul Toxicol Pharmacol. 2009 Dec;55(3):330-9. doi: 10.1016/j.yrtph.2009.08.005. Epub 2009 Aug 15.
In 1993, based on observations of subclinical neurological effects in workers, the United States Environmental Protection Agency (US EPA) published a Reference Concentration (RfC) of 0.05 microg/m(3) for manganese (Mn). The geometric mean exposure concentration, 150 microg/m(3) respirable Mn, was considered the lowest observable adverse effect level (LOAEL), and uncertainty factors (UFs) were applied to account for sensitive populations, database limitations, a LOAEL, subchronic exposure, and potential differences in toxicity of different forms of Mn. Based on a review of more recent literature, we propose two alternate Mn RfCs. Of 12 more recent occupational studies of eight cohorts with chronic exposure durations, examining subclinical neurobehavioral effects, predominantly on the motor system, three were considered appropriate for development of an RfC. All three studies yielded no observable adverse effect levels (NOAELs) of approximately 60 microg/m(3) respirable Mn. Converting the occupational NOAEL to a human equivalent concentration (HEC) of 21microg/m(3) (for continuous exposure) and applying a UF of 10 to account for intraspecies variability yielded an RfC of 2microg/m(3). We also derived a similar RfC (7 microg/m(3)) using an Mn benchmark dose (BMD) as the point of departure. Overall confidence in both RfCs is medium.
1993 年,基于对工人亚临床神经影响的观察,美国环境保护署(US EPA)发布了锰(Mn)的参考浓度(RfC)为 0.05 微克/立方米。可吸入 Mn 的几何平均暴露浓度为 150 微克/立方米,被认为是最低可观察到的不良效应水平(LOAEL),并应用不确定性因素(UFs)来考虑敏感人群、数据库限制、LOAEL、亚慢性暴露以及不同形式的 Mn 的潜在毒性差异。基于对最新文献的审查,我们提出了两种替代 Mn RfC。在最近对 8 个具有慢性暴露时间的队列进行的 12 项职业研究中,有 12 项研究检查了亚临床神经行为效应,主要是运动系统,其中 3 项被认为适合制定 RfC。所有三项研究的可观察到的不良效应水平(NOAEL)均约为 60 微克/立方米可吸入 Mn。将职业性 NOAEL 转换为 21 微克/立方米(用于连续暴露)的人类等效浓度(HEC),并应用 10 的 UF 来考虑种内变异性,得出 RfC 为 2 微克/立方米。我们还使用 Mn 基准剂量(BMD)作为出发点,得出了类似的 RfC(7 微克/立方米)。这两个 RfC 的总体置信度均为中等。